TY - JOUR
T1 - Evaluation of simultaneous binding of Chromomycin A3 to the multiple sites of DNA by the new restriction enzyme assay
AU - Murase, Hirotaka
AU - Noguchi, Tomoharu
AU - Sasaki, Shigeki
N1 - Funding Information:
This study was supported by a Grant-in-Aid for Scientific Research (B) (Grant Number 15H04633 for S.S.) from the Japan Society for the Promotion Sciences (JSPS). H.M. is grateful for the support by the Academic Challenge Program 2015 from Kyushu University.
Funding Information:
This study was supported by a Grant-in-Aid for Scientific Research (B) (Grant Number 15H04633 for S.S.) from the Japan Society for the Promotion Sciences ( JSPS ). H.M. is grateful for the support by the Academic Challenge Program 2015 from Kyushu University.
Publisher Copyright:
© 2018 Elsevier Ltd
PY - 2018/6/1
Y1 - 2018/6/1
N2 - Chromomycin A3 (CMA3) is an aureolic acid-type antitumor antibiotic. CMA3 forms dimeric complexes with divalent cations, such as Mg2+, which strongly binds to the GC rich sequence of DNA to inhibit DNA replication and transcription. In this study, the binding property of CMA3 to the DNA sequence containing multiple GC-rich binding sites was investigated by measuring the protection from hydrolysis by the restriction enzymes, AccII and Fnu4HI, for the center of the CGCG site and the 5′-GC↓GGC site, respectively. In contrast to the standard DNase I footprinting method, the DNA substrates are fully hydrolyzed by the restriction enzymes, therefore, the full protection of DNA at all the cleavable sites indicates that CMA3 simultaneously binds to all the binding sites. The restriction enzyme assay has suggested that CMA3 has a high tendency to bind the successive CGCG sites and the CGG repeat.
AB - Chromomycin A3 (CMA3) is an aureolic acid-type antitumor antibiotic. CMA3 forms dimeric complexes with divalent cations, such as Mg2+, which strongly binds to the GC rich sequence of DNA to inhibit DNA replication and transcription. In this study, the binding property of CMA3 to the DNA sequence containing multiple GC-rich binding sites was investigated by measuring the protection from hydrolysis by the restriction enzymes, AccII and Fnu4HI, for the center of the CGCG site and the 5′-GC↓GGC site, respectively. In contrast to the standard DNase I footprinting method, the DNA substrates are fully hydrolyzed by the restriction enzymes, therefore, the full protection of DNA at all the cleavable sites indicates that CMA3 simultaneously binds to all the binding sites. The restriction enzyme assay has suggested that CMA3 has a high tendency to bind the successive CGCG sites and the CGG repeat.
UR - http://www.scopus.com/inward/record.url?scp=85045241114&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045241114&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2018.04.013
DO - 10.1016/j.bmcl.2018.04.013
M3 - Article
C2 - 29657103
AN - SCOPUS:85045241114
SN - 0960-894X
VL - 28
SP - 1832
EP - 1835
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
IS - 10
ER -